We applied this in our GEMM tumors, a model that develops neuroblastoma because of Cre-conditional activation of the human copy of MYCN in dopamine beta-hydroxylase (Dbh) expressing cells—thus, human MYCN expression should be excluded from non-cancer cells. Here, DBH is linked to neuroblastoma.